Evidence and expert consensus based German guidelines for the use of repetitive transcranial magnetic stimulation in depression

References

• Abdel Latif A, Nasreldin M, Abdel Kader A, Fathy H, Moussa S, Basheer M, Elsheikh A, Madbouly N. 2020. A randomized study comparing the short-term neurocognitive outcome of electroconvulsive therapy versus repetitive transcranial magnetic stimulation in the treatment of patients with depression. J Psychiatr Pract. 26(1):23–36.
   PubMed Web of Science ®Google Scholar
• Abdelnaim MA, Langguth B, Deppe M, Mohonko A, Kreuzer PM, Poeppl TB, Hebel T, Schecklmann M. 2019. Anti-suicidal efficacy of repetitive transcranial magnetic stimulation in depressive patients: a retrospective analysis of a large sample. Front Psychiat. 10:929.
   PubMed Web of Science ®Google Scholar
• Baeken C, Wu GR, VAN Heeringen K. 2019. Placebo aiTBS attenuates suicidal ideation and frontopolar cortical perfusion in major depression. Transl Psychiatry. 9(1):38.
   PubMedGoogle Scholar
• Bajbouj M, Padberg F. 2014. A perfect match: noninvasive brain stimulation and psychotherapy. Eur Arch Psychiatry Clin Neurosci. 264(Suppl 1):S27–S33.
   PubMedGoogle Scholar
• Barker AT, Jalinous R, Freeston IL. 1985. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1(8437):1106–1107.
   PubMed Web of Science ®Google Scholar
• Beam W, Borckardt JJ, Reeves ST, George MS. 2009. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimul. 2(1):50–54.
   PubMed Web of Science ®Google Scholar
• Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, et al. 2018. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet. 391(10131):1683–1692.
   PubMed Web of Science ®Google Scholar
• Bozzay ML, Primack J, Barredo J, Philip NS. 2020. Transcranial magnetic stimulation to reduce suicidality – a review and naturalistic outcomes. J Psychiatr Res. 125:106–112.
   PubMed Web of Science ®Google Scholar
• Bulteau S, Beynel L, Marendaz C, Dall'Igna G, Pere M, Harquel S, Chauvin A, Guyader N, Sauvaget A, Vanelle JM, et al. 2019. Twice-daily neuronavigated intermittent theta burst stimulation for bipolar depression: a randomized sham-controlled pilot study. Neurophysiol Clin. 49(5):371–375.
   PubMed Web of Science ®Google Scholar
• Cao X, Deng C, Su X, Guo Y. 2018. Response and remission rates following high-frequency vs. low-frequency repetitive transcranial magnetic stimulation (rTMS) over right DLPFC for treating major depressive disorder (MDD): a meta-analysis of randomized double-blind trials. Front Psychiatry. 9:413.
   PubMed Web of Science ®Google Scholar
• Caulfield KA, Stern AP. 2020. Therapeutic high-frequency repetitive transcranial magnetic stimulation concurrently improves mood and anxiety in patients using benzodiazepines. Neuromodulation. 23(3):380–383.
   PubMed Web of Science ®Google Scholar
• Chen L, Hudaib AR, Hoy KE, Fitzgerald PB. 2019. Is rTMS effective for anxiety symptoms in major depressive disorder? An efficacy analysis comparing left-sided high-frequency, right-sided low-frequency, and sequential bilateral rTMS protocols. Depress Anxiety. 36(8):723–731.
   PubMed Web of Science ®Google Scholar
• Cole EJ, Stimpson KH, Bentzley BS, Gulser M, Cherian K, Tischler C, Nejad R, Pankow H, Choi E, Aaron H, et al. 2020. Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression. Am J Psychiatry. 177(8):716–726.
   PubMed Web of Science ®Google Scholar
• Cole J, Bright K, Gagnon L, Mcgirr A. 2019. A systematic review of the safety and effectiveness of repetitive transcranial magnetic stimulation in the treatment of peripartum depression. J Psychiatr Res. 115:142–150.
   PubMed Web of Science ®Google Scholar
• Corlier J, Burnette E, Wilson AC, Lou JJ, Landeros A, Minzenberg MJ, Leuchter AF. 2020. Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control. J Affect Disord. 265:272–277.
   PubMed Web of Science ®Google Scholar
• Cox EQ, Killenberg S, Frische R, Mcclure R, Hill M, Jenson J, Pearson B, Meltzer-Brody SE. 2020. Repetitive transcranial magnetic stimulation for the treatment of postpartum depression. J Affect Disord. 264:193–200.
   PubMed Web of Science ®Google Scholar
• Damar U, Lee Kaye H, Smith NA, Pennell PB, Rotenberg A. 2020. Safety and tolerability of repetitive transcranial magnetic stimulation during pregnancy: a case report and literature review. J Clin Neurophysiol. 37(2):164–169.
   PubMed Web of Science ®Google Scholar
• Deng L, Sun X, Qiu S, Xiong Y, Li Y, Wang L, Wei Q, Wang D, Liu M. 2017. Interventions for management of post-stroke depression: a Bayesian network meta-analysis of 23 randomized controlled trials. Sci Rep. 7(1):16466.
   PubMedGoogle Scholar
• Deppe M, Abdelnaim M, Hebel T, Kreuzer PM, Poeppl TB, Langguth B, Schecklmann M. 2021. Concomitant lorazepam use and antidepressive efficacy of repetitive transcranial magnetic stimulation in a naturalistic setting. Eur Arch Psychiatry Clin Neurosci. 271(1):61–67.
   PubMed Web of Science ®Google Scholar
• Desbeaumes Jodoin V, Miron JP, Lesperance P. 2019. Safety and efficacy of accelerated repetitive transcranial magnetic stimulation protocol in elderly depressed unipolar and bipolar patients. Am J Geriatr Psychiatry. 27(5):548–558.
   PubMed Web of Science ®Google Scholar
• DGPPN. 2015. S3-Leitlinie Unipolare Depression.
   Google Scholar
• Donse L, Padberg F, Sack AT, Rush AJ, Arns M. 2018. Simultaneous rTMS and psychotherapy in major depressive disorder: clinical outcomes and predictors from a large naturalistic study. Brain Stimul. 11(2):337–345.
   PubMed Web of Science ®Google Scholar
• Dunlop K, Sheen J, Schulze L, Fettes P, Mansouri F, Feffer K, Blumberger DM, Daskalakis ZJ, Kennedy SH, Giacobbe P, et al. 2020. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: a three-arm, blinded, randomized controlled trial. Brain Stimul. 13(2):337–340.
   PubMed Web of Science ®Google Scholar
• Duprat R, Desmyter S, Rudi de R, van Heeringen K, Van den Abbeele D, Tandt H, Bakic J, Pourtois G, Dedoncker J, Vervaet M, et al. 2016. Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: a fast road to remission? J Affect Disord. 200:6–14.
   Google Scholar
• Filipcic I, Simunovic Filipcic I, Milovac Z, Sucic S, Gajsak T, Ivezic E, Basic S, Bajic Z, Heilig M. 2019. Efficacy of repetitive transcranial magnetic stimulation using a figure-8-coil or an H1-coil in treatment of major depressive disorder; a randomized clinical trial. J Psychiatr Res. 114:113–119.
   PubMed Web of Science ®Google Scholar
• Fisicaro F, Lanza G, Grasso AA, Pennisi G, Bella R, Paulus W, Pennisi M. 2019. Repetitive transcranial magnetic stimulation in stroke rehabilitation: review of the current evidence and pitfalls. Ther Adv Neurol Disord. 12:1756286419878317.
   Web of Science ®Google Scholar
• Fitzgerald PB, Chen L, Richardson K, Daskalakis ZJ, Hoy KE. 2020. A pilot investigation of an intensive theta burst stimulation protocol for patients with treatment resistant depression. Brain Stimul. 13(1):137–144.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Daskalakis ZJ, Hoy KE. 2020. Benzodiazepine use and response to repetitive transcranial magnetic stimulation in major depressive disorder. Brain Stimul. 13(3):694–695.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Hoy K, Mcqueen S, Maller JJ, Herring S, Segrave R, Bailey M, Been G, Kulkarni J, Daskalakis ZJ. 2009. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology. 34(5):1255–1262.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Hoy KE, Reynolds J, Singh A, Gunewardene R, Slack C, Ibrahim S, Daskalakis ZJ. 2020. A pragmatic randomized controlled trial exploring the relationship between pulse number and response to repetitive transcranial magnetic stimulation treatment in depression. Brain Stimul. 13(1):145–152.
   PubMed Web of Science ®Google Scholar
• Fox MD, Buckner RL, White MP, Greicius MD, Pascual-Leone A. 2012. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatry. 72(7):595–603.
   PubMed Web of Science ®Google Scholar
• Ganho-Avila A, Poleszczyk A, Mohamed MMA, Osorio A. 2019. Efficacy of rTMS in decreasing postnatal depression symptoms: a systematic review. Psychiatry Res. 279:315–322.
   PubMed Web of Science ®Google Scholar
• Gellersen HM, Kedzior KK. 2019. Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and meta-analysis. BMC Psychiatry. 19(1):139.
   PubMedGoogle Scholar
• George MS, Lisanby SH, Avery D, Mcdonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, et al. 2010. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 67(5):507–516.
   PubMed Web of Science ®Google Scholar
• Giacobbe P, Mithani K, Meng Y, Vila-Rodriguez F, Daskalakis ZJ, Downar J, Blumberger DM. 2020. Evaluation of the effects of rTMS on self-reported quality of life and disability in treatment-resistant depression: a three-D study. J Affect Disord. 268:127–133.
   PubMed Web of Science ®Google Scholar
• Griffiths C, O'Neill-Kerr A, DE Vai R, DA Silva K. 2019. Impact of repetitive transcranial magnetic stimulation on generalized anxiety disorder in treatment-resistant depression. Ann Clin Psychiatry. 31(4):236–241.
   PubMed Web of Science ®Google Scholar
• Gwynette MF, Lowe DW, Henneberry EA, Sahlem GL, Wiley MG, Alsarraf H, Russo SB, Joseph JE, Summers PM, Lohnes L, et al. 2020. Treatment of adults with autism and major depressive disorder using transcranial magnetic stimulation: an open label pilot study. Autism Res. 13(3):346–351.
   PubMed Web of Science ®Google Scholar
• Haesebaert F, Moirand R, Schott-Pethelaz AM, Brunelin J, Poulet E. 2018. Usefulness of repetitive transcranial magnetic stimulation as a maintenance treatment in patients with major depression. World J Biol Psychiatry. 19(1):74–78.
   PubMed Web of Science ®Google Scholar
• Hai-Jiao W, Ge T, Li-NA Z, Deng C, DA X, Shan-Shan C, Liu L. 2020. The efficacy of repetitive transcranial magnetic stimulation for Parkinson disease patients with depression. Int J Neurosci. 130(1):19–27.
   PubMed Web of Science ®Google Scholar
• Hebel T, Abdelnaim M, Deppe M, Langguth B, Schecklmann M. 2020. Attenuation of antidepressive effects of transcranial magnetic stimulation in patients whose medication includes drugs for psychosis. J Psychopharmacol. 34(10):1119–1124.
   PubMed Web of Science ®Google Scholar
• Hebel T, Göllnitz A, Schoisswohl S, Weber FC, Abdelnaim M, Wetter TC, Rupprecht R, Langguth B, Schecklmann M. 2021. A direct comparison of neuronavigated and non-neuronavigated intermittent theta burst stimulation in the treatment of depression. Brain Stimul. 14(2):335–343.
   PubMed Web of Science ®Google Scholar
• Hebel T, Schecklmann M, Langguth B. 2020. Transcranial magnetic stimulation in the treatment of depression during pregnancy: a review. Arch Womens Ment Health. 23(4):469–478.
   PubMed Web of Science ®Google Scholar
• Herbsman T, Avery D, Ramsey D, Holtzheimer P, Wadjik C, Hardaway F, Haynor D, George MS, Nahas Z. 2009. More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry. 66(5):509–515.
   PubMed Web of Science ®Google Scholar
• Hernandez MJ, Reljic T, VAN Trees K, Phillips S, Hashimie J, Bajor L, Yehl J, Mckenzie BC, Burke C, Sullivan GA, et al. 2020. Impact of comorbid PTSD on outcome of repetitive transcranial magnetic stimulation (TMS) for veterans with depression. J Clin Psychiatry. 81(4):19m13152.
   PubMed Web of Science ®Google Scholar
• Herwig U, Fallgatter AJ, Hoppner J, Eschweiler GW, Kron M, Hajak G, Padberg F, Naderi-Heiden A, Abler B, Eichhammer P, et al. 2007. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br J Psychiatry. 191:441–448.
   PubMed Web of Science ®Google Scholar
• Herwig U, Satrapi P, Schönfeldt-Lecuona C. 2003. Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr. 16(2):95–99.
   PubMed Web of Science ®Google Scholar
• Hett D, Marwaha S. 2020. Repetitive transcranial magnetic stimulation in the treatment of bipolar disorder. Ther Adv Psychopharmacol. 10:2045125320973790.
   Web of Science ®Google Scholar
• Hızlı Sayar G, Ozten E, Tufan E, Cerit C, Kağan G, Dilbaz N, Tarhan N. 2014. Transcranial magnetic stimulation during pregnancy. Arch Womens Ment Health. 17(4):311–315.
   PubMed Web of Science ®Google Scholar
• Hoy KE, Mcqueen S, Elliot D, Herring SE, Maller JJ, Fitzgerald PB. 2019. A pilot investigation of repetitive transcranial magnetic stimulation for post-traumatic brain injury depression: safety, tolerability, and efficacy. J Neurotrauma. 36(13):2092–2098.
   PubMed Web of Science ®Google Scholar
• Hsu JH, Downar J, Vila-Rodriguez F, Daskalakis ZJ, Blumberger DM. 2019. Impact of prior treatment on remission with intermittent theta burst versus high-frequency repetitive transcranial magnetic stimulation in treatment resistant depression. Brain Stimul. 12(6):1553–1555.
   PubMed Web of Science ®Google Scholar
• Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. 2005. Theta burst stimulation of the human motor cortex. Neuron. 45(2):201–206.
   PubMed Web of Science ®Google Scholar
• Hunter AM, Minzenberg MJ, Cook IA, Krantz DE, Levitt JG, Rotstein NM, Chawla SA, Leuchter AF. 2019. Concomitant medication use and clinical outcome of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder. Brain Behav. 9(5):e01275.
   PubMed Web of Science ®Google Scholar
• Iseger TA, Padberg F, Kenemans JL, Gevirtz R, Arns M. 2017. Neuro-cardiac-guided TMS (NCG-TMS): probing DLPFC-sgACC-vagus nerve connectivity using heart rate – first results. Brain Stimul. 10(5):1006–1008.
   PubMed Web of Science ®Google Scholar
• Johansen SL, Robakis TK, Williams KE, Rasgon NL. 2019. Management of perinatal depression with non-drug interventions. BMJ. 364:l322.
   PubMedGoogle Scholar
• Kaster TS, Fitzgerald PB, Downar J, Vila-Rodriguez F, Daskalakis ZJ, Blumberger DM. 2020. Considerable evidence supports rTMS for treatment-resistant depression. J Affect Disord. 263:549–551.
   PubMed Web of Science ®Google Scholar
• Kaster TS, Knyahnytska Y, Noda Y, Downar J, Daskalakis ZJ, Blumberger DM. 2020. Treatment-emergent mania with psychosis in bipolar depression with left intermittent theta-burst rTMS. Brain Stimul. 13(3):705–706.
   PubMed Web of Science ®Google Scholar
• Keck ME, Welt T, Muller MB, Erhardt A, Ohl F, Toschi N, Holsboer F, Sillaber I. 2002. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology. 43(1):101–109.
   PubMed Web of Science ®Google Scholar
• Kiebs M, Hurlemann R, Mutz J. 2019. Repetitive transcranial magnetic stimulation in non-treatment-resistant depression. Br J Psychiatry. 215(2):445–446.
   PubMed Web of Science ®Google Scholar
• Kim DR, Epperson N, Pare E, Gonzalez JM, Parry S, Thase ME, Cristancho P, Sammel MD, O'Reardon JP. 2011. An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. J Womens Health (Larchmt). 20(2):255–261.
   PubMed Web of Science ®Google Scholar
• Kim DR, Wang E, Mcgeehan B, Snell J, Ewing G, Iannelli C, O'Reardon JP, Sammel MD, Epperson CN. 2019. Randomized controlled trial of transcranial magnetic stimulation in pregnant women with major depressive disorder. Brain Stimul. 12(1):96–102.
   PubMed Web of Science ®Google Scholar
• Kito S, Miyazi M, Nakatani H, Matsuda Y, Yamazaki R, Okamoto T, Igarashi Y. 2019. Effectiveness of high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with treatment-resistant depression: a randomized clinical trial of 37.5-minute vs 18.75-minute protocol. Neuropsychopharmacol Rep. 39(3):203–208.
   PubMedGoogle Scholar
• Konstantinou GN, Vigod SN, Mehta S, Daskalakis ZJ, Blumberger DM. 2020. A systematic review of non-invasive neurostimulation for the treatment of depression during pregnancy. J Affect Disord. 272:259–268.
   PubMed Web of Science ®Google Scholar
• Koponen LM, Goetz SM, Tucci DL, Peterchev AV. 2020. Sound comparison of seven TMS coils at matched stimulation strength. Brain Stimul. 13(3):873–880.
   PubMed Web of Science ®Google Scholar
• Kreuzer PM, Schecklmann M, Lehner A, Wetter TC, Poeppl TB, Rupprecht R, DE Ridder D, Landgrebe M, Langguth B. 2015. The ACDC pilot trial: targeting the anterior cingulate by double cone coil rTMS for the treatment of depression. Brain Stimul. 8(2):240–246.
   PubMed Web of Science ®Google Scholar
• Leblhuber F, Steiner K, Fuchs D. 2019. Treatment of patients with geriatric depression with repetitive transcranial magnetic stimulation. J Neural Transm. 126(8):1105–1110.
   PubMed Web of Science ®Google Scholar
• Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, DI Lazzaro V, Filipovic SR, Grefkes C, Hasan A, Hummel FC, et al. 2020. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014–2018). Clin Neurophysiol. 131(2):474–528.
   PubMed Web of Science ®Google Scholar
• Lefaucheur JP, Andre-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, DE Carvalho M, DE Ridder D, et al. 2014. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 125(11):2150–2206.
   PubMed Web of Science ®Google Scholar
• Lerner AJ, Wassermann EM, Tamir DI. 2019. Seizures from transcranial magnetic stimulation 2012–2016: results of a survey of active laboratories and clinics. Clin Neurophysiol. 130(8):1409–1416.
   PubMed Web of Science ®Google Scholar
• Li CT, Cheng CM, Chen MH, Juan CH, Tu PC, Bai YM, Jeng JS, Lin WC, Tsai SJ, Su TP. 2020. Antidepressant efficacy of prolonged intermittent theta burst stimulation monotherapy for recurrent depression and comparison of methods for coil positioning: a randomized, double-blind, sham-controlled study. Biol Psychiatry. 87(5):443–450.
   PubMed Web of Science ®Google Scholar
• Liu C, Wang M, Liang X, Xue J, Zhang G. 2019. Efficacy and safety of high-frequency repetitive transcranial magnetic stimulation for poststroke depression: a systematic review and meta-analysis. Arch Phys Med Rehabil. 100(10):1964–1975.
   PubMed Web of Science ®Google Scholar
• Maneeton B, Maneeton N, Woottiluk P, Likhitsathian S. 2020. Repetitive transcranial magnetic stimulation combined with antidepressants for first episode of major depressive disorder. Curr Neuropharmacol. 18(9):852–860.
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Kito S, Igarashi Y, Shigeta M. 2020. Efficacy and safety of deep transcranial magnetic stimulation in office workers with treatment-resistant depression: a randomized, double-blind, sham-controlled trial. Neuropsychobiology. 79(3):208–213.
   PubMed Web of Science ®Google Scholar
• McClintock SM, Reti IM, Carpenter LL, Mcdonald WM, Dubin M, Taylor SF, Cook IA, O'Reardon J, Husain MM, Wall C, et al. 2018. Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry. 79(1):16cs10905.
   Web of Science ®Google Scholar
• Miljevic A, Bailey NW, Herring SE, Fitzgerald PB. 2019. Potential predictors of depressive relapse following repetitive transcranial magnetic stimulation: a systematic review. J Affect Disord. 256:317–323.
   PubMed Web of Science ®Google Scholar
• Minzenberg MJ, Leuchter AF. 2019. The effect of psychotropic drugs on cortical excitability and plasticity measured with transcranial magnetic stimulation: Implications for psychiatric treatment. J Affect Disord. 253:126–140.
   PubMed Web of Science ®Google Scholar
• Mutz J, Vipulananthan V, Carter B, Hurlemann R, Fu CHY, Young AH. 2019. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ. 364:l1079.
   PubMedGoogle Scholar
• Needs P, Mote SD, Manocchia M, King JD, Szuba DD, Lustig SL, Shah VN. 2019. Psychotherapy and psychopharmacology utilization following repetitive transcranial magnetic stimulation (rTMS) in patients with major depressive disorder. Psychiatry Res. 278:51–55.
   PubMed Web of Science ®Google Scholar
• Nordmann G, Azorina V, Langguth B, Schecklmann M. 2015. A systematic review of non-motor rTMS induced motor cortex plasticity. Front Hum Neurosci. 9:416.
   PubMed Web of Science ®Google Scholar
• Nursey J, Sbisa A, Knight H, Ralph N, Cowlishaw S, Forbes D, O'Donnell M, Hinton M, Cooper J, Hopwood M, et al. 2020. Exploring theta burst stimulation for post-traumatic stress disorder in Australian veterans-a pilot study. Mil Med. 185(9–10):e1770–e1778.
   PubMed Web of Science ®Google Scholar
• O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, Mcdonald WM, Avery D, Fitzgerald PB, Loo C, et al. 2007. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 62(11):1208–1216.
   PubMed Web of Science ®Google Scholar
• Ozcan S, Gica S, Gulec H. 2020. Suicidal behavior in treatment resistant major depressive disorder patients treated with transmagnetic stimulation(TMS) and its relationship with cognitive functions. Psychiatry Res. 286:112873.
   PubMed Web of Science ®Google Scholar
• Pan F, Shen Z, Jiao J, Chen J, Li S, Lu J, Duan J, Wei N, Shang D, Hu S, et al. 2020. Neuronavigation-guided rTMS for the treatment of depressive patients with suicidal ideation: a double-blind, randomized, sham-controlled trial. Clin Pharmacol Ther. 108(4):826–832.
   Google Scholar
• Pascual-Leone A, Rubio B, Pallardo F, Catala MD. 1996. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 348(9022):233–237.
   PubMed Web of Science ®Google Scholar
• Patel R, Silla F, Pierce S, Theule J, Girard TA. 2020. Cognitive functioning before and after repetitive transcranial magnetic stimulation (rTMS): a quantitative meta-analysis in healthy adults. Neuropsychologia. 141:107395.
   PubMed Web of Science ®Google Scholar
• Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, Demitrack MA, Hovav S, Janicak PG, George MS. 2016. Can medication free, treatment-resistant, depressed patients who initially respond to TMS be maintained off medications? A prospective, 12-month multisite randomized pilot study. Brain Stimul. 9(2):251–257.
   PubMed Web of Science ®Google Scholar
• Rachid F. 2018. Maintenance repetitive transcranial magnetic stimulation (rTMS) for relapse prevention in with depression: a review. Psychiatry Res. 262:363–372.
   PubMed Web of Science ®Google Scholar
• Rossi S, Antal A, Bestmann S, Bikson M, Brewer C, Brockmoller J, Carpenter LL, Cincotta M, Chen R, Daskalakis JD, Basis of this Article began with a Consensus Statement from the IFCN workshop on "present, F.O.T.M.S.S.E.G.S.O.U.T.A., et al. 2021. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: expert guidelines. Clin Neurophysiol. 132(1):269–306.
   PubMed Web of Science ®Google Scholar
• Rossi S, Hallett M, Rossini PM, Pascual-Leone A, & Safety of T.M.S.C.G. 2009. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 120(12):2008–2039.
   PubMed Web of Science ®Google Scholar
• Rumi DO, Gattaz WF, Rigonatti SP, Rosa MA, Fregni F, Rosa MO, Mansur C, Myczkowski ML, Moreno RA, Marcolin MA. 2005. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry. 57(2):162–166.
   PubMed Web of Science ®Google Scholar
• Rutherford G, Lithgow B, Moussavi Z. 2020. Transcranial magnetic stimulation safety from operator exposure perspective. Med Biol Eng Comput. 58(2):249–256.
   PubMed Web of Science ®Google Scholar
• Sackeim HA, Aaronson ST, Carpenter LL, Hutton TM, Mina M, Pages K, Verdoliva S, West WS. 2020. Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation. J Affect Disord. 277:65–74.
   PubMed Web of Science ®Google Scholar
• Schönfeldt-Lecuona C, Cardenas-Morales L, Moreno-Aguirre A, Dorn K, Langguth B, Bruhl AB, Kammer T, Herwig U. 2012. Effect of 1 Hz repetitive transcranial magnetic stimulation over the auditory cortex on audiometry and otoacustic emissions. Brain Topogr. 25(3):241–247.
   PubMed Web of Science ®Google Scholar
• Schönfeldt-Lecuona C, Lefaucheur JP, Cardenas-Morales L, Wolf RC, Kammer T, Herwig U. 2010. The value of neuronavigated rTMS for the treatment of depression. Neurophysiol Clin. 40(1):37–43.
   PubMed Web of Science ®Google Scholar
• Schönfeldt-Lecuona C, Thielscher A, Freudenmann RW, Kron M, Spitzer M, Herwig U. 2005. Accuracy of stereotaxic positioning of transcranial magnetic stimulation. Brain Topogr. 17(4):253–259.
   PubMed Web of Science ®Google Scholar
• Schulze L, Remington G, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J. 2017. Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression. J Psychopharmacol. 31(3):312–319.
   PubMed Web of Science ®Google Scholar
• Sehatzadeh S, Daskalakis ZJ, Yap B, Tu H-A, Palimaka S, Bowen JM, O’Reilly DJ. 2019. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a meta-analysis of randomized controlled trials over 2 decades. J Psychiatry Neurosci. 44(3):151–163.
   PubMed Web of Science ®Google Scholar
• Semkovska M, Mcloughlin DM. 2010. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 68(6):568–577.
   PubMed Web of Science ®Google Scholar
• Senova S, Cotovio G, Pascual-Leone A, Oliveira-Maia AJ. 2019. Durability of antidepressant response to repetitive transcranial magnetic stimulation: systematic review and meta-analysis. Brain Stimul. 12(1):119–128.
   PubMed Web of Science ®Google Scholar
• Serafini G, Canepa G, Aguglia A, Amerio A, Bianchi D, Magnani L, Dell'Osso B, Pompili M, Fitzgerald PB, Amore M. 2020. Effects of repetitive transcranial magnetic stimulation on suicidal behavior: A systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 105:109981.
   PubMed Web of Science ®Google Scholar
• Shen X, Liu M, Cheng Y, Jia C, Pan X, Gou Q, Liu X, Cao H, Zhang L. 2017. Repetitive transcranial magnetic stimulation for the treatment of post-stroke depression: a systematic review and meta-analysis of randomized controlled clinical trials. J Affect Disord. 211:65–74.
   PubMed Web of Science ®Google Scholar
• Shere SS, Baliga SP, Mehta UM, Girimaji SC, Thirthalli J. 2020. Treatment emergent affective switch in depression: a possible role of theta burst stimulation. Brain Stimul. 13(2):492–493.
   PubMed Web of Science ®Google Scholar
• Siddiqi SH, Trapp NT, Hacker CD, Laumann TO, Kandala S, Hong X, Trillo L, Shahim P, Leuthardt EC, Carter AR, et al. 2019. Repetitive transcranial magnetic stimulation with resting-state network targeting for treatment-resistant depression in traumatic brain injury: a randomized, controlled, double-blinded pilot study. J Neurotrauma. 36(8):1361–1374.
   PubMed Web of Science ®Google Scholar
• Sonmez AI, Camsari DD, Nandakumar AL, Voort JLV, Kung S, Lewis CP, Croarkin PE. 2019. Accelerated TMS for depression: a systematic review and meta-analysis. Psychiatry Res. 273:770–781.
   PubMed Web of Science ®Google Scholar
• Tastevin M, Baumstarck K, Groppi F, Cermolacce M, Lagrange G, Lancon C, Richieri R. 2020. Double cone coil rTMS efficacy for treatment-resistant depression: a prospective randomized controlled trial. Brain Stimul. 13(1):256–258.
   PubMed Web of Science ®Google Scholar
• Teng S, Guo Z, Peng H, Xing G, Chen H, He B, Mcclure MA, Mu Q. 2017. High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: Session-dependent efficacy: a meta-analysis. Eur Psychiatr. 41(1):75–84.
   PubMedGoogle Scholar
• Trapp NT, Bruss J, King Johnson M, Uitermarkt BD, Garrett L, Heinzerling A, Wu C, Koscik TR, TEN Eyck P, Boes AD. 2020. Reliability of targeting methods in TMS for depression: beam F3 vs. 5.5 cm. Brain Stimul. 13(3):578–581.
   PubMed Web of Science ®Google Scholar
• Trevizol AP, Goldberger KW, Mulsant BH, Rajji TK, Downar J, Daskalakis ZJ, Blumberger DM. 2019. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant late-life depression. Int J Geriatr Psychiatry. 34(6):822–827.
   PubMed Web of Science ®Google Scholar
• Tsai PY, Lin WS, Tsai KT, Kuo CY, Lin PH. 2020. High-frequency versus theta burst transcranial magnetic stimulation for the treatment of poststroke cognitive impairment in humans. J Psychiatry Neurosci. 45:190060.
   Web of Science ®Google Scholar
• Verduijn J, Verhoeven JE, Milaneschi Y, Schoevers RA, VAN Hemert AM, Beekman ATF, Penninx B. 2017. Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule. BMC Med. 15(1):215.
   PubMedGoogle Scholar
• Voigt J, Carpenter L, Leuchter A. 2019. A systematic literature review of the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in non-treatment resistant patients with major depressive disorder. BMC Psychiatry. 19(1):13.
   PubMedGoogle Scholar
• Wang HN, Wang XX, Zhang RG, Wang Y, Cai M, Zhang YH, Sun RZ, Guo L, Qiao YT, Liu JC, et al. 2017. Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: a randomized controlled trial. Transl Psychiatry. 7(12):1292.
   PubMedGoogle Scholar
• Weigand A, Horn A, Caballero R, Cooke D, Stern AP, Taylor SF, Press D, Pascual-Leone A, Fox MD. 2018. Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites. Biol Psychiatry. 84(1):28–37.
   PubMed Web of Science ®Google Scholar
• Westin GG, Bassi BD, Lisanby SH, Luber B. 2014. Determination of motor threshold using visual observation overestimates transcranial magnetic stimulation dosage: safety implications. Clin Neurophysiol. 125(1):142–147.
   PubMed Web of Science ®Google Scholar
• Wilkes S, Ona C, Yang M, Liu P, Benton A, Lustik M, Coleman J. 2020. Impacts of rTMS on refractory depression and comorbid PTSD symptoms at a military treatment facility. Mil Med. 185(9-10):e1420–e1427.
   PubMed Web of Science ®Google Scholar
• Williams NR, Sudheimer KD, Bentzley BS, Pannu J, Stimpson KH, Duvio D, Cherian K, Hawkins J, Scherrer KH, Vyssoki B, et al. 2018. High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression. Brain. 141(3):e18.
   Google Scholar
• Yang LL, Zhao D, Kong LL, Sun YQ, Wang ZY, Gao YY, Li N, Lu L, Shi L, Wang XY, et al. 2019. High-frequency repetitive transcranial magnetic stimulation (rTMS) improves neurocognitive function in bipolar disorder. J Affect Disord. 246:851–856.
   PubMed Web of Science ®Google Scholar
• Yuan S, Tirrell E, Gobin AP, Carpenter LL. 2019. Effect of previous electroconvulsive therapy on subsequent response to transcranial magnetic stimulation for major depressive disorder. Neuromodulation. 23(3):393–398.
   Google Scholar
• Zhou L, Guo Z, Xing G, Peng H, Cai M, Chen H, Mcclure MA, He L, Xiong L, He B, et al. 2018. Antidepressant effects of repetitive transcranial magnetic stimulation over prefrontal cortex of parkinson's disease patients with depression: a meta analysis. Front Psychiatry. 9:769.
   PubMed Web of Science ®Google Scholar
• Zis P, Shafique F, Hadjivassiliou M, Blackburn D, Venneri A, Iliodromiti S, Mitsikostas DD, Sarrigiannis PG. 2020. Safety, tolerability, and nocebo phenomena during transcranial magnetic stimulation: a systematic review and meta-analysis of placebo-controlled clinical trials. Neuromodulation. 23(3):291–300.
   PubMed Web of Science ®Google Scholar